Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D I Abrams

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|May 24, 1997
Genotypic-resistance assays and antiretroviral therapyS G Deeks, D I Abrams
Seminars in Oncology|June 1, 1987
Alpha interferon therapy of AIDS-associated Kaposi's sarcomaD I Abrams, P A Volberding
Seminars in Oncology|September 1, 1986
Alpha interferon therapy of AIDS-associated Kaposi's sarcomaD I Abrams, P A Volberding
International Journal of STD & AIDS|November 1, 2000
Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of lifeD I Abrams, C Steinhart, R Frascino
Advances in Experimental Medicine and Biology|January 1, 1985
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective studyD I Abrams, T Mess, P A Volberding
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)S Oie, M A Jacobson, D I Abrams
JAMA|July 25, 1986
Lupus anticoagulant in the acquired immunodeficiency syndromeE J Bloom, D I Abrams, G Rodgers
Annals of the New York Academy of Sciences|January 1, 1984
Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective studyD I Abrams, B J Lewis, P A Volberding
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 monthsA A Scitovsky, M W Cline, D I Abrams
Advances in Experimental Medicine and Biology|January 1, 1985
Isolated thrombocytopenia in homosexual men--longitudinal follow-upD I Abrams, D D Kiprov, P A Volberding
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|May 24, 1997
Genotypic-resistance assays and antiretroviral therapyS G Deeks, D I Abrams
Seminars in Oncology|June 1, 1987
Alpha interferon therapy of AIDS-associated Kaposi's sarcomaD I Abrams, P A Volberding
Seminars in Oncology|September 1, 1986
Alpha interferon therapy of AIDS-associated Kaposi's sarcomaD I Abrams, P A Volberding
International Journal of STD & AIDS|November 1, 2000
Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of lifeD I Abrams, C Steinhart, R Frascino
Advances in Experimental Medicine and Biology|January 1, 1985
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective studyD I Abrams, T Mess, P A Volberding
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)S Oie, M A Jacobson, D I Abrams
JAMA|July 25, 1986
Lupus anticoagulant in the acquired immunodeficiency syndromeE J Bloom, D I Abrams, G Rodgers
Annals of the New York Academy of Sciences|January 1, 1984
Lymphadenopathy: endpoint or prodrome? Update of a 24-month prospective studyD I Abrams, B J Lewis, P A Volberding
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 monthsA A Scitovsky, M W Cline, D I Abrams
Advances in Experimental Medicine and Biology|January 1, 1985
Isolated thrombocytopenia in homosexual men--longitudinal follow-upD I Abrams, D D Kiprov, P A Volberding
Pageof 9